Valuation: Renascience Inc.

Market Cap 13.35B 84.73M 75.76M 70.1M 63.47M 119M 8.06B 121M 844M 334M 4.22B 318M 311M P/E 2025
118x
P/E 2026 -71.8x
Enterprise Value 9.95B 63.14M 56.46M 52.23M 47.29M 88.51M 6.01B 89.96M 629M 249M 3.14B 237M 232M EV / Sales 2025
87.3x
EV / Sales 2026 290x
Free-Float
43.01%
Yield 2025 *
-
Yield 2026 -
1 day-2.42%
1 week-6.56%
Current month-17.25%
1 month-20.44%
3 months-35.36%
6 months-17.95%
Current year-31.57%
1 week 931
Extreme 931
1,048
1 month 931
Extreme 931
1,313
Current year 931
Extreme 931
2,185
1 year 931
Extreme 931
2,228
3 years 263
Extreme 263
3,310
5 years 263
Extreme 263
3,310
10 years 263
Extreme 263
3,310
Manager TitleAgeSince
President 65 2025-05-31
Chief Tech/Sci/R&D Officer - -
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member 72 2025-05-31
Director/Board Member 67 2025-05-31
Chairman 65 2020-03-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.42%-6.56%-50.08%+100.62% 87.24M
+0.45%+1.76%+54.96%+118.11% 1,135B
+0.94%+4.20%+39.86%+75.69% 635B
+0.39%+0.46%+25.77%+97.40% 505B
+1.43%+4.56%+46.20%+66.91% 378B
-3.21%-3.66%+60.72%+35.68% 358B
-0.41%+2.23%+22.48%+48.54% 295B
+0.23%+3.28%+2.57%+21.89% 266B
+1.22%+2.81%+52.40%+63.37% 237B
+1.70%+1.60%+31.21%+102.44% 193B
Average -0.03%+1.02%+28.61%+73.07% 400.37B
Weighted average by Cap. +0.24%+1.63%+41.40%+81.03%

Financials

2025 2026
Net sales 132M 838K 749K 693K 628K 1.17M 79.71M 1.19M 8.34M 3.3M 41.69M 3.14M 3.08M 68M 432K 386K 357K 323K 605K 41.06M 615K 4.3M 1.7M 21.48M 1.62M 1.59M
Net income 113M 717K 641K 593K 537K 1.01M 68.23M 1.02M 7.14M 2.82M 35.69M 2.69M 2.63M -301M -1.91M -1.71M -1.58M -1.43M -2.68M -182M -2.72M -19.02M -7.52M -95.06M -7.17M -7.02M
Net Debt -1.8B -11.42M -10.21M -9.45M -8.55M -16.01M -1.09B -16.27M -114M -44.96M -568M -42.85M -41.94M -3.4B -21.59M -19.31M -17.86M -16.17M -30.27M -2.05B -30.77M -215M -85.03M -1.07B -81.04M -79.31M
Projected Income Statement - Annual - Renascience Inc.
Logo Renascience Inc.
Renascience Inc is mainly engaged in the development and sale of pharmaceuticals and medical devices. The company is engaged in the research and development of various modalities (pharmaceuticals, medical devices, artificial intelligence (AI) solutions) to solve problems in the medical field, in collaboration with physicians. The Company is engaged in the development of drugs for four non-infectious aging-related diseases: cancer, diabetes, respiratory diseases, and cardiovascular diseases. The Company is also engaged in the solve of other medical issues such as diseases of women and children, and COVID-19 infection.
Employees
-
Date Price Change Volume
26-10-26 JP¥969.00 -2.42% 107,800
26-10-23 JP¥993.00 +0.30% 312,900
26-10-22 JP¥990.00 -3.04% 127,600
26-10-21 JP¥1,021.00 +0.69% 122,900
26-10-20 JP¥1,014.00 -1.07% 79,800

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Renascience Inc.
  1. Stock Market
  2. Stocks
  3. 4889 Stock